Heron Therapeutics | HRTX - Los Gastos Financieros De La Deuda

Precio De Mercado
0.85
Cambio Diario
0.03 4.10%
Mensual
-12.06%
Anual
-55.34%
Q2 Expectativa
0.83




Los Gastos Financieros De La Deuda Cambio Fecha
ALKERMES USD 12.28M 7.63M 2025-12
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amarin USD 3K 5K 2024-12
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Anika Therapeutics 189.44M 1.76M 2025-09
Arrowhead Research USD 22.5M 811K 2025-12
Eisai JPY 1.43B 12M 2025-12
Esperion Therapeutics USD 22.64M 585K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 20.6M 217K 2025-12
Ligand Pharmaceuticals USD 910K 243K 2025-09
Merck USD 412M 85M 2025-12
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Neurocrine Biosciences USD 1.1M 0 2024-03
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.89M 387K 2025-12
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sangamo BioSciences 97.56M 11.39M 2025-06
Surmodics USD 884K 5K 2024-09
Ultragenyx Pharmaceutical USD 19M 4.85M 2025-12
Veracyte USD 2K 1000 2023-12
Vertex Pharmaceuticals USD 3.3M 0 2025-12